Somatus Valuation, Funding & Investors
Somatus is valued at $2.5B as of February 2022.
Last Somatus valuation
$2.5B
Series E · Feb 2022
Last Somatus funding round
$325M
Series E · Feb 2022
Cumulative funding Somatus raised
$465M
across 5 funding rounds
Key investors in Somatus
Flare Capital Partners
Deerfield
Longitude Capital
Optum Ventures
The Blue Venture Fund
Inova Health System
About Somatus
Somatus is a McLean-headquartered value-based care provider for kidney disease patients. It integrates clinical services, technology, and nephrology partnerships with health plans to promote home dialysis and transplants. Founded in 2017, the company serves over 100,000 patients through 100 clinics nationwide.
Founded
2016
HQ
Washington, DCWebsite
Status
Privately held
Customer focus
B2B
Revenue model
Services, Subscription
Valuation
$2.5B (Feb 2022)
Somatus Valuation
Somatus is currently valued at $2.5B, based on its Series E in February 2022.
The $325M round was led by Wellington Management, with participation from The Blue Venture Fund, Fidelity, Inova Health System, Flare Capital Partners, Elevance Health and 5 other investors.
Somatus' valuation has grown 52x from $48M at its Series B in April 2018 to $2.5B in February 2022, across 2 priced rounds.
Somatus valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Feb 2022 | Series E | $2.5B |
| Apr 2018 | Series B | $48M |
Somatus Funding History
Somatus has raised a total of $465M across 5 funding rounds.
Somatus' first fundraising round was a $5M Series A in May 2017. The most recent completed round was a $325M Series E in February 2022.
Somatus funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Feb 2022 | Series E | Wellington Management (lead); The Blue Venture Fund; Fidelity; Inova Health System; Flare Capital Partners; Elevance Health; GIC; RA Capital Management; Optum Ventures; Longitude Capital; Deerfield | $325M | $2.5B | Somatus, founded in 2016 and headquartered in McLean, Virginia, provides value-based kidney care through a comprehensive model that integrates multidisciplinary community-based care teams, personalized services like at-home dialysis, and a data-driven technology platform to coordinate and monitor care for patients with kidney disease or at risk of progression. The company partners with payers, health systems, and provider groups under value-based contracts to delay disease progression, improve quality of life, and lower costs. In February 2022, Somatus raised over $325 million in an oversubscribed Series E funding round led by Wellington Management, achieving a post-money valuation exceeding $2.5 billion. New investors included RA Capital Management, GIC, Fidelity Management & Research Company, and others, while returning investors comprised Elevance Health (Anthem), Optum Ventures, Inova Health System, Blue Venture Fund, Longitude Capital, Deerfield Management, and Flare Capital Partners. This round more than doubled the company's total funding to nearly $500 million, with proceeds aimed at expanding its care model nationwide. By early 2022, Somatus had demonstrated rapid growth, adding six new health plan partnerships (including a multiyear deal with Anthem), over 1,000 hires to reach more than 1,350 employees, and serving members across 34 states in Medicare, Medicare Advantage, Medicaid, and commercial plans. The company projected membership growth to well over 150,000 lives by year-end 2022. |
| Jun 2021 | Series D | - | $60M | - | Somatus is a value-based kidney care company providing integrated care for patients with kidney disease, partnering with health plans, primary care groups, and health systems to deliver in-home care and support across Medicare, Medicare Advantage, Medicaid, and commercial plans. The company operates in 34 US states and focuses on delaying disease progression, improving quality of life, and lowering costs. Prior to the queried June 2021 period, Somatus raised a Series C of $64M in June 2020 led by Optum Ventures, Longitude Capital, and Deerfield Management, with participation from Blue Venture Fund, Flare Capital, and Town Hall Ventures. Anthem reportedly participated in a $60M Series D round in June 2021. Somatus demonstrated strong growth leading into 2021, launching six new health plan partners and establishing value-based partnerships with provider groups that year. The company expanded its team by over 1,000 members to more than 1,350 and aimed to serve 150,000 insured patients in 2022. Following the 2021 rounds, Somatus closed an oversubscribed Series E of $325M+ on February 23, 2022, led by Wellington Management with participation from Anthem, Blue Venture Fund, Optum Ventures, Inova Health System, Deerfield, Flare Capital, Longitude Capital, Fidelity, RA Capital, and GIC, valuing the company over $2.5B post-money and bringing total funding to nearly $500M. Funds supported further expansion of its kidney care model. Subsequent rounds included later financings reaching over $1.41B total raised, with a Series Junior-2NV valuation of $4.98B in June 2025 and a Series G of $75M at $5.05B post-money in June 2025. |
| Jun 2020 | Series C | Deerfield (lead); Longitude Capital (lead); Optum Ventures (lead); Town Hall Ventures; Flare Capital Partners | $64M | - | Somatus is a value-based kidney care provider offering vertically integrated services to patients with or at risk of kidney disease, operating across six US states and managing over 20,000 patients as of June 2020. The company completed a $64 million Series C funding round on June 23, 2020, led by Longitude Capital and co-led by Optum Ventures and Deerfield Management, with participation from Blue Venture Fund, Flare Capital Partners, and Town Hall Ventures. This brought total capital raised to over $105 million since its founding in 2016, following prior rounds including a $5 million Series A in 2017 and an $11 million Series B in 2018. The funding supports national expansion, headcount growth to its 300-person team, new partnerships, and technology investments like a patient-facing mobile app for condition monitoring, transplant tracking, and physician connections. Somatus aims to enhance kidney care and dialysis delivery, positioning itself as a preferred partner for health plans amid transformations in the sector. |
| Apr 2018 | Series B | Flare Capital Partners (lead); The Blue Venture Fund; Inova Health System; Andy Slavitt | $11M | $48M | Somatus is a kidney care company providing value-based care solutions for chronic kidney disease (CKD) and end-stage renal disease (ESRD) patients, focusing on cost-efficient home care, dialysis, and management services delivered through multidisciplinary teams and technology platforms. Founded in 2016, the company partners with health systems and payers to improve clinical outcomes and reduce costs in the kidney care market. On April 11, 2018, Somatus raised $11 million in a Series B funding round led by Flare Capital Partners, with participation from The Blue Venture Fund (BlueCross BlueShield Venture Partners), Inova Health System, and an innovation firm founded by Andy Slavitt. The post-money valuation for this round was $48.43 million. Proceeds were allocated to strengthen technology, services, and expansion into new markets. This followed a $5 million raise in May 2017 from undisclosed investors, bringing total funding at the time to over $16 million. Somatus, led by CEO Dr. Ikenna Okezie with prior experience at DaVita, Advisory Board Company, and McKinsey, aimed to address misaligned incentives in legacy kidney care providers. |
| May 2017 | Series A | - | $5M | - | Somatus raised $5 million in its Series A funding round on April 20, 2017. The company, founded in 2016, provides value-based kidney care services. |
Who has invested in Somatus?
13 investors have backed Somatus across its funding rounds, including Flare Capital Partners, Deerfield, Longitude Capital, Optum Ventures, The Blue Venture Fund and Inova Health System.
Lead investors include Wellington Management, Deerfield, Longitude Capital, Optum Ventures and Flare Capital Partners.
Somatus Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| Boston, MA | 3 | Lead | Apr 2018 | |
| Chicago, IL | 2 | Participant | Apr 2018 | |
| Washington, DC | 2 | Participant | Apr 2018 | |
| Boston, MA | 2 | Lead | Jun 2020 | |
| San Francisco, CA | 2 | Lead | Jun 2020 | |
| New York City, NY | 2 | Lead | Jun 2020 | |
| Boston, MA | 1 | Lead | Feb 2022 | |
| Boston, MA | 1 | Participant | Feb 2022 | |
| New York City, NY | 1 | Participant | Jun 2020 | |
| United States | 1 | Participant | Feb 2022 | |
 Singapore | 1 | Participant | Feb 2022 | |
This data is available for Pro users. Sign up to see all 13 Somatus investors. Start Free Trial | ||||
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small}
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Somatus
Somatus has acquired 1 company to date.
Last acquisition by Somatus was on April 28th 2022. Somatus acquired Lumiata for undisclosed valuation.
Latest Acquisitions by Somatus
| Description | Lumiata is a healthcare AI platform built on over 120 million patient records and clinical expertise, offering machine learning tools and pre-trained models for providers and payers. The company enables predictive analytics in underwriting, care management, and risk reduction from offices in Silicon Valley, Dallas, and Guadalajara. Backers include Khosla Ventures, Blue Venture Fund, Defy.vc, and Allegis Capital. |
| HQ Country | |
| HQ City | Washington, DC |
| Deal Date | 28 Apr 2022 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Somatus acquisitions and their M&A valuation multiples. Start Free Trial | |
Somatus Competitors
Somatus competitors include listed companies like Privia Health and Schrödinger, and private ones like Strive Health, Aledade, MediTrust Health and Cityblock Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Denver, CO | Private | - | - | $1.8B | - | |
| Washington, DC | Private | $475M | - | $3.5B | 7.4x | |
 Shanghai | Private | $154M | - | $1.4B | 9.3x | |
| New York City, NY | Private | - | - | $5.7B | - | |
| United States | Publicly listed | $2.1B | $44M | $2.6B | 0.9x | |
| United States | Publicly listed | $256M | ($96M) | $2.3B | 7.9x |
Somatus Public Comps
Somatus is still privately-owned, but its public comps include Privia Health, Tieto, Clover Health, Schrödinger, Qingdao Baheal Medical, Alignment Healthcare, Omnicell, Indegene, EverCommerce and CCC Intelligent Solutions.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.1B | $44M | 1.0x | 0.9x | 50.2x | 15.3x | |||
| $2.1B | $186M | 1.3x | 1.4x | 15.2x | 7.9x | |||
| $1.9B | ($84M) | 1.1x | 0.8x | (25.8x) | 34.1x | |||
| $256M | ($96M) | 7.6x | 7.9x | (20.3x) | (14.0x) | |||
| $1.1B | $139M | 1.9x | 1.9x | 15.1x | 16.8x | |||
| $3.9B | $45M | 0.4x | 0.3x | 31.6x | 10.0x | |||
| $1.2B | $92M | 1.2x | 1.1x | 15.0x | 8.1x | |||
| $366M | $68M | 3.7x | 3.3x | 19.9x | 18.2x | |||
This data is available for Pro users. Sign up to see all Somatus competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Somatus
| When was Somatus founded? | Somatus was founded in 2016. |
| Where is Somatus headquartered? | Somatus is headquartered in Washington, DC, United States. |
| Is Somatus publicly listed? | No, Somatus is a private, VC-backed company. |
| What is Somatus' valuation? | Somatus was last valued at $2.5B in its Series E in February 2022. |
| How much funding has Somatus raised? | Somatus has raised $465M across 5 funding rounds. |
| What was Somatus' last funding round? | Somatus' last funding round was a $325M Series E in February 2022, led by Wellington Management. |
| Who are Somatus' investors? | Somatus' investors include Flare Capital Partners, The Blue Venture Fund, Inova Health System, Optum Ventures, Longitude Capital, Deerfield, Wellington Management, Fidelity, Town Hall Ventures, Elevance Health and 3 others. |
| Which companies are comparable to Somatus? | Companies comparable to Somatus include Strive Health, Aledade, MediTrust Health, Cityblock Health, Privia Health and Schrödinger. |
| How many companies has Somatus acquired? | Somatus has acquired 1 company, including Lumiata. |
See companies similar to Somatus
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.